CAU
DORM icon

Caxton Associates (UK)’s Dorman Products DORM Stock Holding History

Caxton Associates (UK)’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Sell
12,663
-2,005
-14% -$239K 0.03% 312
2025
Q4 		$1.81M Sell
14,668
-3,042
-17% -$411K 0.04% 227
2025
Q3 		$2.76M Buy
17,710
+12,398
+233% +$1.78M 0.07% 143
2025
Q2 		$652K Hold
5,312
– – 0.02% 374
2025
Q1 		$640K Buy
+5,312
New +$678K 0.02% 423

Other funds holding DORM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Caxton Associates (UK)'s DORM Position: Q1 2026 in Review

Caxton Associates (UK) reduced its Dorman Products (DORM) stake by 14% in Q1 2026, selling an estimated $239K and leaving 12,663 shares worth $1.32M. The position accounts for 0.03% of the portfolio, ranked #312.

Caxton Associates (UK) first reported a position in DORM in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.76M in Q3 2025. 318 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

  • Caxton Associates (UK) held 12,663 shares of Dorman Products worth $1.32M as of Q1 2026.
  • Caxton Associates (UK) sold 2,005 Dorman Products shares in Q1 2026, an estimated $239K.
  • Dorman Products made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #312 holding.
  • Caxton Associates (UK) first reported a position in Dorman Products in Q1 2025 and has held it in 5 quarters since.
  • Caxton Associates (UK)'s Dorman Products position peaked at $2.76M in Q3 2025.
  • 318 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.